<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01062685</url>
  </required_header>
  <id_info>
    <org_study_id>2008P000323</org_study_id>
    <nct_id>NCT01062685</nct_id>
  </id_info>
  <brief_title>Near Infrared Spectroscopy (St02)</brief_title>
  <acronym>St02</acronym>
  <official_title>Near Infrared Spectroscopy (NIRS) to Measure Tissue Oxygen Saturation (St02)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beth Israel Deaconess Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hutchinson Technology Inc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Astute Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Axis Shield Diagnostics Ltd</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Beth Israel Deaconess Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall hypotheses of this project is that Near Infrared Spectroscopy (NIRS) can be used
      to identify morbidity, mortality, and resource utilization in patients with sepsis and septic
      shock.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Near-infrared spectroscopy (NIRS) noninvasively measures peripheral tissue oxygen saturation
      (StO2), offering promise as a guide in the early treatment of severe sepsis; however, the
      role and utility of this technology is still evolving.

      There are three main NIRS measurements reported in the literature: continuous StO2
      measurement (StO2 initial), StO2 occlusion slope (StO2 downslope) in response to VOT testing
      and StO2 recovery slope (StO2 upslope) in response to vasoocclusive testing. The purpose of
      this study is to assesses the association of each of these parameters with severity of
      illness, organ dysfunction and death.

      This study will utilize the Hutchinson InSpectra StO2 tissue oxygenation monitor, which is
      FDA approved for use in monitoring patients during circulatory or perfusion examinations of
      skeletal muscle, or when there is a suspicion of compromised circulation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2009</start_date>
  <completion_date type="Actual">January 2010</completion_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Organ Dysfunction and Severity of Illness</measure>
    <time_frame>time 0 - 24 hrs</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>In hospital</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">186</enrollment>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>Shock Cohort</arm_group_label>
    <description>The SHOCK cohort will meet the American College of Chest physicians/Society of Critical Care Medicine criteria for septic shock, specifically:
1) Suspected infection
2) Any two of four criteria of systemic inflammatory response:
a. Temperature &gt; 100.4° or &lt; 96.8° F
b. Heart rate &gt; 90 beats/minute
c. Respiratory rate &gt; 20 breaths/min. or PaCO2 &lt; 32 mm Hg
d. WBC &gt;12,000 or &lt; 4000 cells/µL or &gt; 10% bands
3) Hypotension despite adequate fluid resuscitation:
a. SBP &lt; 90 mm Hg after 20cc/kg crystalloid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sepsis cohort</arm_group_label>
    <description>The SEPSIS cohort will to meet:
1) Suspected infection
2) Any two of four criteria of systemic inflammatory response:
a. Temperature &gt; 100.4° or &lt; 96.8° F
b. Heart rate &gt; 90 beats/minute
c. Respiratory rate &gt; 20 breaths/min. or PaCO2 &lt; 32 mm Hg
d. WBC &gt;12,000 or &lt; 4000 cells/µL or &gt; 10% bands
3) Absence of refractory hypotension</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-Infected controls</arm_group_label>
    <description>The third cohort will be comprised of uninfected ED control patients who met the criteria of no suspected infection, no SIRS criteria met and no evidence of hypoperfusion that are age and sex matched on a 1:1 basis with the shock cohort.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Near-infrared spectroscopy assessment</intervention_name>
    <description>The InSpectra StO2 Tissue Oxygenation Monitor (model 650; Hutchinson Technology, Hutchinson, MN, USA) with probes spaced at 15 mm will be utilized to obtain StO2 measurements.
Following a minimum initial five-minute stabilization period, the initial StO2 will be measurement and then a Vasoocclusive Testing Procedure (VOT) will be performed using an automated tourniquet (Delfi Tourniquet System; Delfi Medical Innovations, Inc, Vancouver, BC, Canada), insufflated to 50 mmHg over the patient's SBP for a period of three minutes.</description>
    <arm_group_label>Shock Cohort</arm_group_label>
    <arm_group_label>Sepsis cohort</arm_group_label>
    <arm_group_label>Non-Infected controls</arm_group_label>
    <other_name>NIRS assessment</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood, serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients presenting to the Emergency Department (ED) of one of three large, urban, tertiary
        care facilities.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        There will be three cohorts enrolled in this study: (1) Septic Shock, (2) Sepsis and (3)
        Controls.

        Inclusion Criteria:

        Listed on the Cohorts description.

        Exclusion Criteria:

        All patient cohorts will share common set of exclusion criteria:

          -  Age &lt; 18 years

          -  Pregnancy

          -  Established &quot;Do Not Resuscitate&quot; orders prior to enrollment

          -  Primary diagnosis of:

               -  Acute traumatic or burn injury

               -  Acute cerebrovascular event

               -  Acute coronary syndrome

               -  Acute pulmonary edema

               -  Cardiac dysrhythmia

               -  Acute and active gastrointestinal bleeding

               -  Acute drug overdose

               -  Requirement for immediate surgery

               -  Inability to obtain written informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nathan I Shapiro, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beth Israel Deaconess Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Skibsted S, Arnold R, Sherwin R, Singh S, Lundy D, Nelson T, Puskarich MA, Trzeciak S, Jones AE, Shapiro NI. The association of near infrared spectroscopy-derived StO2 measurements and biomarkers of endothelial activation in sepsis. Intern Emerg Med. 2013 Sep;8(6):529-36. doi: 10.1007/s11739-013-0973-3. Epub 2013 Jul 4.</citation>
    <PMID>23824446</PMID>
  </results_reference>
  <results_reference>
    <citation>Shapiro NI, Arnold R, Sherwin R, O'Connor J, Najarro G, Singh S, Lundy D, Nelson T, Trzeciak SW, Jones AE; Emergency Medicine Shock Research Network (EMShockNet). The association of near-infrared spectroscopy-derived tissue oxygenation measurements with sepsis syndromes, organ dysfunction and mortality in emergency department patients with sepsis. Crit Care. 2011;15(5):R223. doi: 10.1186/cc10463. Epub 2011 Sep 22.</citation>
    <PMID>21939529</PMID>
  </results_reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 3, 2010</study_first_submitted>
  <study_first_submitted_qc>February 3, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 4, 2010</study_first_posted>
  <last_update_submitted>April 25, 2017</last_update_submitted>
  <last_update_submitted_qc>April 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beth Israel Deaconess Medical Center</investigator_affiliation>
    <investigator_full_name>Nathan Shapiro</investigator_full_name>
    <investigator_title>Associate Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>septic shock</keyword>
  <keyword>sepsis</keyword>
  <keyword>St02</keyword>
  <keyword>Near Infrared Spectroscopy</keyword>
  <keyword>NIRS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

